Benefit/ Risk considerations Based on the documentation submitted by the applicant including the proposal for implementation of a pregnancy prevention programme and the scientific discussion within the Committee, the CPMP considered that the benefit/ risk ratio of Isotretinoin / Lurantal / Rexidal / Scheritonin / Trivane is positive for the agreed indications.